Allogeneic umbilical cord-derived mesenchymal stem cell exosome intranasal therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic umbilical cord-derived mesenchymal stem cell exosome intranasal therapy, covering 2025-04-17 to 2025-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosome Intranasal Instillations for Stroke [Phase 1]